Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
T89 in chronic stable angina pectoris
NCT00797953Phase 2Completed
- Sponsor
- Tasly Group
- Start
- Feb 2007
- Primary completion
- Dec 2009
- Countries
- 1
01
Overview
A Phase 2 trial of Compound Danshen in angina pectoris, sponsored by Tasly Group. Started Feb 2007; status: completed.
02
Drugs
Compound Danshen
03
Conditions
angina pectoris
Beyond the preview
Go deeper on NCT00797953.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00797953.